Hematological Malignancies in Giant Cell Arteritis: a French population-based study.

Date publication

avril 2021

Journal

Rheumatology (Oxford, England)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BONNOTTE Bernard , Pr MARTIN Laurent , Pr MAYNADIE Marc , Dr MOUNIER Morgane

Tous les auteurs :
Greigert H, Mounier M, Arnould L, Creuzot-Garcher C, Ramon A, Martin L, Tarris G, Ponnelle T, Audia S, Bonnotte B, Maynadie M, Samson M

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33792672

Résumé

An increased risk of hematological malignancies (HM) has been reported in giant cell arteritis (GCA) patients. Our study aimed to investigate the incidence and the type of HM occurring in GCA.

Mots clés

giant cell arteritis, hematological malignancies, population-based study

Référence

Rheumatology (Oxford). 2021 Apr 1;: